(Bloomberg) China’s latest attempt to reverse the nation’s foreign investment slump includes pledges to offer overseas firms better tax treatment and make it easier for them to obtain visas, as officials try to allay fears about doing business in the world’s second-largest economy. Most Read from BloombergOutsider Milei Upends Argentina’s Election With Primary WinAmerica’s Fastest Growing City Is Embracing ‘Yellowstone’ ManiaZuckerberg Says ‘Time to Move On’ From Musk Cage FightGoldman Pencil
Japan approves Moderna, AstraZeneca Covid vax
A Japanese government panel of experts approved two Covid-19 vaccines developed by US drug maker Moderna Inc. and the UK-based AstraZeneca Plc, with the Health Ministry expected to formaliae the approval of the use of the two jabs on Friday.
| 22 May 2021 6:45 AM GMT
TOKYO: A Japanese government panel of experts approved two Covid-19 vaccines developed by US drug maker Moderna Inc. and the UK-based AstraZeneca Plc, with the Health Ministry expected to formaliae the approval of the use of the two jabs on Friday.
The expected approval, based on the expert panel s assessment of Japan s own clinical trials of the vaccines as well as those from overseas and the efficacy of the vaccines against Covid-19, will bring the number of jabs available in the country to three. Japan is already using the vaccine developed by US pharmaceutical giant Pfizer. (IANS)
Welcome To IANS Live - INTERNATIONAL - Japan approves Moderna, AstraZeneca Covid vax ianslive.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ianslive.in Daily Mail and Mail on Sunday newspapers.
January 11, 2021 | 7:54 pm Font Size
AAA
THE PHILIPPINE government is finalizing talks on coronavirus vaccine orders and might start the rollout next month, according to vaccine czar Carlito G. Galvez, Jr.
“It is expected that we can start our rollout this first quarter in February, with an early rollout possibly by the COVAX vaccine either by Pfizer, AstraZeneca, Johnson & Johnson, or Sinovac,” he told a Senate hearing on the state’s vaccination program on Monday.
About 40 million doses will come from the COVID-19 Vaccines Global Access (COVAX) facility for 20 million to 30 million people, Mr. Galvez told senators.
COVAX, co-led by Gavi, the Vaccine Alliance, Coalition for Epidemic Preparedness Innovations and the World Health Organization (WHO), aims to ensure the availability of COVID-19 vaccines to all countries.